RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAIs solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.
Registrars:
Key Personnel
CEO:
James Renwick McCullough
Non-Executive Director:
Robert (Rob) Graham Naylor, Erik Kristian Lium, Catherine Coste